Thirty-Day Outcomes After Bilateral Total Hip Arthroplasty in a Nationwide Cohort
Background: Approximately 42% of patients with end-stage osteoarthritis have bilateral disease. Although bilateral total hip arthroplasty (THA) is physiologically demanding, certain patients may benefit from simultaneous rather than staged bilateral procedures. This study examines the intraoperative...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2020-09-01
|
| Series: | Arthroplasty Today |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S235234412030087X |
| _version_ | 1818148093078536192 |
|---|---|
| author | Jessica S. Morton, MD Benjamin S. Kester, MD Nima Eftekhary, MD Jonathan Vigdorchik, MD William J. Long, MD, FRCSC Stavros G. Memtsoudis, MD Lazaros A. Poultsides, MD, MSc, PhD |
| author_facet | Jessica S. Morton, MD Benjamin S. Kester, MD Nima Eftekhary, MD Jonathan Vigdorchik, MD William J. Long, MD, FRCSC Stavros G. Memtsoudis, MD Lazaros A. Poultsides, MD, MSc, PhD |
| author_sort | Jessica S. Morton, MD |
| collection | DOAJ |
| description | Background: Approximately 42% of patients with end-stage osteoarthritis have bilateral disease. Although bilateral total hip arthroplasty (THA) is physiologically demanding, certain patients may benefit from simultaneous rather than staged bilateral procedures. This study examines the intraoperative differences and 30-day outcomes in patients receiving bilateral THA compared with those who underwent unilateral THA. Methods: Patients undergoing THA were selected from the National Surgical Quality Improvement Program database from 2008 to 2015. Patients were selected according to those with primary and concurrent coding for Current Procedural Terminology 27130. Thirty-day complications were recorded, and multivariate analyses were performed to determine whether concurrent THA was a risk factor for poor outcomes. Results: A total of 97,804 patients and 587 patients who underwent unilateral and bilateral THA, respectively, were identified. Patients who underwent bilateral procedures were younger (57.3 vs 64.6 years, P < .001), were of lower body mass index (29.2 vs 30.2, P < .001), and had fewer comorbidities than patients who underwent unilateral procedures. Length of stay was not increased for bilateral recipients (3.13 vs 2.93 days, P = .308), although fewer were discharged to home (62.8% vs 77.6%, P < .001). The bilateral recipients required postoperative transfusions at a higher rate (29.8% vs 10.9%, P < .001) and had an increased incidence of deep wound infections on univariate analysis (1.2% vs 0.3%, P = .002). There was no increased risk of superficial infection, medical complications, or thromboembolic events for the bilateral cohort. Conclusions: Although bilateral THA recipients are younger with fewer preoperative comorbidities, bilateral THA is associated with an increased rate of transfusion in a nationwide setting. With this knowledge, specific interventions should be instituted to target these procedure-specific risks. |
| first_indexed | 2024-12-11T12:45:39Z |
| format | Article |
| id | doaj.art-8b29e853bffa474bbf74a5df8f5aaf27 |
| institution | Directory Open Access Journal |
| issn | 2352-3441 |
| language | English |
| last_indexed | 2024-12-11T12:45:39Z |
| publishDate | 2020-09-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Arthroplasty Today |
| spelling | doaj.art-8b29e853bffa474bbf74a5df8f5aaf272022-12-22T01:06:50ZengElsevierArthroplasty Today2352-34412020-09-0163405409Thirty-Day Outcomes After Bilateral Total Hip Arthroplasty in a Nationwide CohortJessica S. Morton, MD0Benjamin S. Kester, MD1Nima Eftekhary, MD2Jonathan Vigdorchik, MD3William J. Long, MD, FRCSC4Stavros G. Memtsoudis, MD5Lazaros A. Poultsides, MD, MSc, PhD6Division of Adult Reconstruction, Department of Orthopaedic Surgery, NYU Langone Medical Center, Hospital for Joint Disease, New York, NY, USA; Corresponding author. Hospital for Joint Disease, 301 East 17th Street Suite 1402, New York, NY 10003, USA. Tel.: +1 212 598 6000.Division of Adult Reconstruction, Department of Orthopaedic Surgery, NYU Langone Medical Center, Hospital for Joint Disease, New York, NY, USADivision of Adult Reconstruction, Department of Orthopaedic Surgery, NYU Langone Medical Center, Hospital for Joint Disease, New York, NY, USADivision of Adult Reconstruction, Department of Orthopaedic Surgery, Hospital for Special Surgery, New York, NY, USADivision of Adult Reconstruction, Department of Orthopaedic Surgery, NYU Langone Medical Center, Hospital for Joint Disease, New York, NY, USADepartment of Anesthesiology, Hospital for Special Surgery, New York, NY, USADivision of Adult Reconstruction, Department of Orthopaedic Surgery, NYU Langone Medical Center, Hospital for Joint Disease, New York, NY, USABackground: Approximately 42% of patients with end-stage osteoarthritis have bilateral disease. Although bilateral total hip arthroplasty (THA) is physiologically demanding, certain patients may benefit from simultaneous rather than staged bilateral procedures. This study examines the intraoperative differences and 30-day outcomes in patients receiving bilateral THA compared with those who underwent unilateral THA. Methods: Patients undergoing THA were selected from the National Surgical Quality Improvement Program database from 2008 to 2015. Patients were selected according to those with primary and concurrent coding for Current Procedural Terminology 27130. Thirty-day complications were recorded, and multivariate analyses were performed to determine whether concurrent THA was a risk factor for poor outcomes. Results: A total of 97,804 patients and 587 patients who underwent unilateral and bilateral THA, respectively, were identified. Patients who underwent bilateral procedures were younger (57.3 vs 64.6 years, P < .001), were of lower body mass index (29.2 vs 30.2, P < .001), and had fewer comorbidities than patients who underwent unilateral procedures. Length of stay was not increased for bilateral recipients (3.13 vs 2.93 days, P = .308), although fewer were discharged to home (62.8% vs 77.6%, P < .001). The bilateral recipients required postoperative transfusions at a higher rate (29.8% vs 10.9%, P < .001) and had an increased incidence of deep wound infections on univariate analysis (1.2% vs 0.3%, P = .002). There was no increased risk of superficial infection, medical complications, or thromboembolic events for the bilateral cohort. Conclusions: Although bilateral THA recipients are younger with fewer preoperative comorbidities, bilateral THA is associated with an increased rate of transfusion in a nationwide setting. With this knowledge, specific interventions should be instituted to target these procedure-specific risks.http://www.sciencedirect.com/science/article/pii/S235234412030087XBilateralTotal hip arthroplastyTransfusionOutcomesInfection |
| spellingShingle | Jessica S. Morton, MD Benjamin S. Kester, MD Nima Eftekhary, MD Jonathan Vigdorchik, MD William J. Long, MD, FRCSC Stavros G. Memtsoudis, MD Lazaros A. Poultsides, MD, MSc, PhD Thirty-Day Outcomes After Bilateral Total Hip Arthroplasty in a Nationwide Cohort Arthroplasty Today Bilateral Total hip arthroplasty Transfusion Outcomes Infection |
| title | Thirty-Day Outcomes After Bilateral Total Hip Arthroplasty in a Nationwide Cohort |
| title_full | Thirty-Day Outcomes After Bilateral Total Hip Arthroplasty in a Nationwide Cohort |
| title_fullStr | Thirty-Day Outcomes After Bilateral Total Hip Arthroplasty in a Nationwide Cohort |
| title_full_unstemmed | Thirty-Day Outcomes After Bilateral Total Hip Arthroplasty in a Nationwide Cohort |
| title_short | Thirty-Day Outcomes After Bilateral Total Hip Arthroplasty in a Nationwide Cohort |
| title_sort | thirty day outcomes after bilateral total hip arthroplasty in a nationwide cohort |
| topic | Bilateral Total hip arthroplasty Transfusion Outcomes Infection |
| url | http://www.sciencedirect.com/science/article/pii/S235234412030087X |
| work_keys_str_mv | AT jessicasmortonmd thirtydayoutcomesafterbilateraltotalhiparthroplastyinanationwidecohort AT benjaminskestermd thirtydayoutcomesafterbilateraltotalhiparthroplastyinanationwidecohort AT nimaeftekharymd thirtydayoutcomesafterbilateraltotalhiparthroplastyinanationwidecohort AT jonathanvigdorchikmd thirtydayoutcomesafterbilateraltotalhiparthroplastyinanationwidecohort AT williamjlongmdfrcsc thirtydayoutcomesafterbilateraltotalhiparthroplastyinanationwidecohort AT stavrosgmemtsoudismd thirtydayoutcomesafterbilateraltotalhiparthroplastyinanationwidecohort AT lazarosapoultsidesmdmscphd thirtydayoutcomesafterbilateraltotalhiparthroplastyinanationwidecohort |